🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a pilot clinical trial investigating the addition of haploidentical...
Status
Completed
Location
St. Jude Children's Research Hospital
Start Date
2014-10-10
Trial ID
NCT02130869
Neuroblastoma is a malignant tumor of the sympathetic nervous system. It is...
Status
Terminated
Location
Columbia Presbyterian Medical Center, Morgan Stanley Children's Hospital New York Presbyterian
Start Date
2003-11
Trial ID
NCT00670410
Treatments Being Tested
The purpose of this prospective phase III, open-label, randomized multicent...
Status
Completed
Location
Chaim Sheba Medical Center
Start Date
2008-01
Trial ID
NCT01191957
Treatments Being Tested
The goal of this clinical research study is to learn if cyclophosphamide gi...
Status
Completed
Location
University of Texas MD Anderson Cancer Center
Start Date
2008-09
Trial ID
NCT00800839
Treatments Being Tested
The purpose of this study is to evaluate the OS, RFS, and TRM after HCT wit...
Status
Unknown
Location
Dong Hwan Kim
Start Date
2008-08
Trial ID
NCT00815568
Treatments Being Tested
Allogeneic (Allo) hematopoietic stem cell transplantation (HSCT) is a recog...
Status
Completed
Location
CHU Amiens
Start Date
2016-02-23
Trial ID
NCT02623309
Treatments Being Tested
To determine the safety of the approach of giving RUXOLITINIB before and af...
Status
Withdrawn
Location
Multiple Locations
Start Date
2015-05
Trial ID
NCT02469974
Treatments Being Tested
The rationale for this trial is to demonstrate the feasibility and safety o...
Status
Completed
Location
Mayo Clinic - Phoenix
Start Date
2011-09
Trial ID
NCT01410344
This study proposes the use of a reduced intensity chemotherapy/radiation t...
Status
Completed
Location
Columbia University Medical Center
Start Date
2002-09
Trial ID
NCT01019876
RATIONALE: Giving low doses of chemotherapy, monoclonal antibodies, and rad...
Status
Completed
Location
Barbara Ann Karmanos Cancer Institute
Start Date
2008-05
Trial ID
NCT00691015